BICO has appointed Erik Gatenholm as Board Chair

The Board of Directors and the CEO assess that having a consolidated management team on site in Uppsala, close to the core operations, will provide the best conditions for continuing to build the organization required for the next phase and for advancing development programs, the company states.

Maria Ekdahl brings more than 20 years of senior finance leadership experience, including her current role as CFO of Nasdaq Stockholm-listed pharmaceutical company, Infant Bacterial Therapeutics, and will join Biovica on October 14, 2026.

CHOSA Oncology has announces the appointment of Bill Cronin to support the company's commercial expansion in the United States.

The newly composed board of Oslo Cancer Cluster brings together leaders from universities, hospitals, biotech companies, global pharmaceutical firms and patient organisations.

The company's Board Chair Maria Rankka has notified the Board of Directors that she will step down as Board Chair and board member of BICO Group AB effective 31 July 2026.

Aplagon has announced the appointment of Carl Lindgren as Chair of its Board of Directors. 

Jessica Martinsson, CEO of the Swedish industry organization SwedenBIO, has been elected Vice Chair of the International Council of Biotechnology Associations (ICBA).